1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde
Related Experiment Videos
Abstract:
Persistent neurochemical changes consistent with parkinsonism have been reported in brains of mice treated with repeated high doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We now report that ethanol or acetaldehyde potentiate MPTP-induced damage to mouse striatum. One hour after the combined treatments (ethanol and MPTP or acetaldehyde and MPTP), the animals exhibited a marked and long-lasting catatonic posture and then returned gradually to apparently normal locomotion. Seven days after MPTP administration, depletion of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in mouse striatum were further potentiated in the group of animals treated with ethanol. This effect was more evident when the treatment was repeated twice and was dose-dependent. Acetaldehyde was more potent than ethanol in enhancing MPTP neurotoxicity. A single exposure to acetaldehyde before and during MPTP treatment produced a very consistent fall of DA, DOPAC and HVA but not serotonin (5HT) or 5-hydroxyindoleacetic acid (5HIAA) in the striatum. This suggests that ethanol effects on MPTP neurotoxicity might be related to acetaldehyde formation.
Insights
Ethanol and acetaldehyde worsen parkinsonism-like brain damage caused by MPTP in mice. Acetaldehyde is more potent, suggesting its formation from ethanol contributes to this enhanced neurotoxicity.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes parkinsonism-like neurochemical changes.
- Ethanol and its metabolite, acetaldehyde, are common neurotoxins.
Purpose of the Study:
- To investigate the potentiating effects of ethanol and acetaldehyde on MPTP-induced neurotoxicity in mice.
- To determine the role of acetaldehyde in ethanol's enhancement of MPTP neurotoxicity.
Main Methods:
- Mice were treated with MPTP alone or in combination with ethanol or acetaldehyde.
- Neurochemical levels of dopamine (DA), DOPAC, HVA, serotonin (5HT), and 5HIAA in the striatum were measured.
- Behavioral changes, including catatonia and locomotion, were observed.
Main Results:
- Combined ethanol/acetaldehyde and MPTP treatment significantly potentiated MPTP-induced depletion of DA, DOPAC, and HVA in the mouse striatum.
- Acetaldehyde was more potent than ethanol in enhancing MPTP neurotoxicity.
- The potentiating effect was dose-dependent and more pronounced with repeated administration.
Conclusions:
- Ethanol and acetaldehyde exacerbate MPTP-induced neurotoxicity, leading to more severe parkinsonian symptoms.
- Acetaldehyde appears to be the primary mediator of ethanol's potentiating effect on MPTP neurotoxicity.
- These findings suggest a potential mechanism for alcohol's contribution to neurodegenerative processes.